(2S,3R,4E)-2-Amino-4-decene-1,3-diol | 235431-59-1 | sc-391656
| 10 mg
| $360.00
| | |
(2S,3R,4E)-2-Amino-4-decene-1,3-diol is an intermediate in the preparation of ceramide derivatives |
Z-L-Dap(Boc)-Obn | 239785-37-6 | sc-396313
| 100 mg
| $320.00
| | |
Z-L-Dap(Boc)-Obn is used in the preparation of N-hydroxybenzamidine derivatives of β-amino-L-alanine |
2-(3,3,3-Trifluoro-2-oxopropylidene)hydrazinecarboxamide | 244268-37-9 | sc-208921
| 500 mg
| $320.00
| | |
|
3-[[2-(Aminocarbonyl)hydrazinylidene]methyl]-4,4,4-trifluoro-2-butenoic Acid Ethyl Ester | 244268-38-0 | sc-209503
| 250 mg
| $300.00
| | |
|
4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide Hydrochloride salt | 247584-10-7 | sc-391298
| 5 g
| $320.00
| | |
4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide Hydrochloride salt is an impurity in the synthesis of Sildenafil |
(3S,4aS,8aS)-2-[(2R,3R)-3-[(3-Amino-2-hydroxy-4-phenythiobutyl]-decahydro-N-(2-hydroxy-1,1-dimethylethyl)-3-isoquinolinecarboxamide | 252186-41-7 | sc-206735
| 1 mg
| $280.00
| | |
|
Fmoc-(2R,3S)-3-phenylisoserine | 252206-27-2 | sc-285573 sc-285573A
| 250 mg 1 g
| $345.00 $1060.00
| | |
|
N6-(2-Aminoethyl)-3-nitro-2,6-pyridinediamine | 252944-01-7 | sc-391953
| 100 mg
| $360.00
| | |
N6-(2-Aminoethyl)-3-nitro-2,6-pyridinediamine is an intermediate in the preparation of glycogen synthase kinase-3 inhibitors |
2′,4′-Dichloro-2-imidazole Acetophenone | 252950-14-4 | sc-391738
| 100 mg
| $300.00
| | |
2′,4′-Dichloro-2-imidazole Acetophenone is an intermediate in the preparation of glycogen synthase kinase-3 (GSK-3) inhibitors |
2-(2-Butyl)-4-{4-[4-(4-methyloxy-phenyl)-piperazin-1-yl]-phenyl}-2,4-dihydro-[1,2,4]-triazol-3-one | 252964-68-4 | sc-206316
| 50 mg
| $290.00
| | |
|